Smoking cessation in Asians: focus on varenicline

References

• Factsheet on Tobacco2014 Available from: http://www.who.int/mediacentre/factsheets/fs339/en/Accessed November 25, 2014
   Google Scholar
• LiQHsiaJYangGPrevalence of smoking in China in 2010N Engl J Med2011364252469247021696322
   PubMed Web of Science ®Google Scholar
• BanerjeeATobacco use patterns among military recruitsMed J Armed Forces India200056192194
   Google Scholar
• Ministry of Health and Family Welfare, Government of IndiaGlobal Adult Tobacco Survey, India Report 2009–2010MumbaiMinistry of Health and Family Welfare, Government of India2010
   Google Scholar
• Korean Ministry of Health and WelfareSmoking Survey 1988–2007[in Korean]SeoulKorean Ministry of Health and Welfare2007
   Google Scholar
• LimMKSohCSTanYSLeongCKSmoking in the Singapore armed forcesSingapore Med J199738250539269360
   PubMedGoogle Scholar
• LevyDTBenjakulSRossHRitthiphakdeeBThe role of tobacco control policies in reducing smoking and deaths in a middle income nation: results from the Thailand SimSmoke simulation modelTob Control2008171535918218810
   PubMed Web of Science ®Google Scholar
• BaillieAJMattickRPHallWQuitting smoking: estimation by meta-analysis of the rate of unaided smoking cessationAust J Public Health19951921291317786936
   PubMedGoogle Scholar
• Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and StaffA clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. public health service reportAm J Prev Med200835215817618617085
   PubMed Web of Science ®Google Scholar
• CoeJWBrooksPRVetelinoMGVarenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessationJ Med Chem200548103474347715887955
   PubMed Web of Science ®Google Scholar
• WangCXiaoDThe Clinical Guidelines for Smoking Cessation in ChinaBeijingWHO Collaborating Centre for Tobacco or Health, Chinese Centre for Disease Control and Prevention, Tobacco Control Office, Chinese Association on Tobacco Control Hospital Tobacco Control Professional Committee2007
   Google Scholar
• GonzalesDRennardSINidesMVarenicline Phase 3 Study GroupVarenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trialJAMA20062961475516820546
   PubMed Web of Science ®Google Scholar
• JorenbyDEHaysJTRigottiNAVarenicline Phase 3 Study GroupEfficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trialJAMA20062961566316820547
   PubMed Web of Science ®Google Scholar
• WestRBakerCLCappelleriJCBushmakinAGEffect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attemptPsychopharmacology (Berl)2008197337137718084743
   PubMed Web of Science ®Google Scholar
• NakamuraMOshimaAFujimotoYMaruyamaNIshibashiTReevesKREfficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose- response study with 40-week follow-up for smoking cessation in Japanese smokersClin Ther20072961040105617692720
   PubMed Web of Science ®Google Scholar
• TsaiSTChoHJChengHSA randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokersClin Ther20072961027103917692719
   PubMed Web of Science ®Google Scholar
• CahillKSteadLFLancasterTNicotine receptor partial agonists for smoking cessationCochrane Database Syst Rev20124CD00610322513936
   PubMed Web of Science ®Google Scholar
• NiauraRHaysJTJorenbyDEThe efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trialCurr Med Res Opin20082471931194118513462
   PubMed Web of Science ®Google Scholar
• RennardSHughesJCinciripiniPMFlexible Quit Date Study GroupA randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit datesNicotine Tob Res201214334335022080588
   PubMed Web of Science ®Google Scholar
• TonstadSTønnesenPHajekPWilliamsKEBillingCBReevesKRVarenicline phase 3 study group. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trialJAMA20062961647116820548
   PubMed Web of Science ®Google Scholar
• KotzDBrownJWestREffectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population studyPsychopharmacology (Berl)20142311374223873417
   PubMed Web of Science ®Google Scholar
• WangCXiaoDChanKPPothiratCGarzaDDaviesSVarenicline for smoking cessation: a placebo-controlled, randomized studyRespirology200914338439219192221
   PubMed Web of Science ®Google Scholar
• FagerströmKNakamuraMChoHJVarenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countriesCurr Med Res Opin20102692165217320666691
   PubMed Web of Science ®Google Scholar
• JainRJhanjeeSJainVA double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in IndiaNicotine Tob Res2014161505723946326
   PubMed Web of Science ®Google Scholar
• ParkPWCasianoEMEscotoLClaveriaAMObservational study of safety and efficacy of varenicline for smoking cessation among Filipino smokersCurr Med Res Opin201127101869187521838412
   PubMed Web of Science ®Google Scholar
• HsuehSCHsuehKCChouMYTuMSA comparison of the effectiveness of varenicline and transdermal nicotine patch in outpatients following a standardized smoking cessation program in Southern TaiwanEval Health Prof Epub2012124
   Google Scholar
• HsuehKCHsuehSCChouMYVarenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in TaiwanPsychopharmacology (Berl)2014231142819282324522334
   PubMed Web of Science ®Google Scholar
• WangCChoBXiaoDWajsbrotDParkPWEffectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practiceInt J Clin Pract201367546947623574106
   PubMed Web of Science ®Google Scholar
• JungJWJeonEJKimJGClinical experience of varenicline for smoking cessationClin Respir J20104421522120887344
   PubMed Web of Science ®Google Scholar
• FreedmanRExacerbation of schizophrenia by vareniclineAm J Psychiatry20071648126917671295
   PubMed Web of Science ®Google Scholar
• KohenIKremenNVarenicline-induced manic episode in a patient with bipolar disorderAm J Psychiatry200716481269127017671294
   PubMed Web of Science ®Google Scholar
• PopkinMKExacerbation of recurrent depression as a result of treatment with vareniclineAm J Psychiatry2008165677418519539
   PubMed Web of Science ®Google Scholar
• GarzaDMurphyMTsengLJRiordanHJChatterjeeAA double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placeboBiol Psychiatry201169111075108221295286
   PubMed Web of Science ®Google Scholar
• TonstadSDaviesSFlammerMRussCHughesJPsychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysisDrug Saf201033428930120297861
   PubMed Web of Science ®Google Scholar
• GunnellDIrvineDWiseLDaviesCMartinRMVarenicline and suicidal behaviour: a cohort study based on data from the general practice research databaseBMJ2009339b380519797344
   PubMed Web of Science ®Google Scholar
• StapletonJAWatsonLSpirlingLIVarenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illnessAddiction2008103114615418028247
   PubMed Web of Science ®Google Scholar
• ThomasKHMartinRMDaviesNMMetcalfeCWindmeijerFGunnellDSmoking cessation treatment and risk of depression, suicide, and self harm in the clinical practice research datalink: prospective cohort studyBMJ2013347f570424124105
   PubMed Web of Science ®Google Scholar
• PasternakBSvanströmHHviidAUse of varenicline versus bupropion and risk of psychiatric adverse eventsAddiction201310871336134323445269
   PubMed Web of Science ®Google Scholar
• ChengappaKNPerkinsKABrarJSVarenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled studyJ Clin Psychiatry201475776577225006684
   PubMed Web of Science ®Google Scholar
• EvinsAECatherCPrattSAMaintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trialJAMA2014311214515424399553
   PubMed Web of Science ®Google Scholar
• AnthenelliRMMorrisCRameyTSEffects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trialAnn Intern Med2013159639040024042367
   PubMed Web of Science ®Google Scholar
• WilliamsJMAnthenelliRMMorrisCDA randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorderJ Clin Psychiatry201273565466022697191
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKSpanglerJGFurbergCDRisk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysisCMAJ2011183121359136621727225
   PubMed Web of Science ®Google Scholar
• ProchaskaJJHiltonJFRisk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysisBMJ2012344e285622563098
   PubMed Web of Science ®Google Scholar
• WareJHVetrovecGWMillerABCardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trialsAm J Ther201320323524623615317
   PubMed Web of Science ®Google Scholar
• UmedaAKatoTYamaneTDoes smoking cessation with varenicline worsen vascular endothelial function?BMJ Open201336e003052
   Web of Science ®Google Scholar
• IgarashiATakumaHFukudaTTsutaniKCost-utility analysis of varenicline, an oral smoking-cessation drug, in JapanPharmacoeconomics200927324726119354344
   PubMed Web of Science ®Google Scholar
• BaeJYKimCHLeeEKEvaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South KoreaValue Health200912suppl 3S70S7320586986
   PubMed Web of Science ®Google Scholar
• HigashiHBarendregtJJCost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation supportAddiction2012107365867021883602
   PubMed Web of Science ®Google Scholar